Specialty Compounding to halt production, sale of sterile drugs

March 11, 2015 7:02 PM

2 0

(Reuters) - Specialty Compounding Llc reached a settlement with the U.S. Food and Drug Administration on Wednesday, barring the company from producing and selling sterile drugs until it receives written approval from the agency.

The FDA filed a complaint with the U.S. District Court for the Western District of Texas in February, alleging that one of Specialty Compounding's sterile injectable drugs had tested positive for bacterial contamination.

Also read: Eletrobras to sell real estate, complete power lines, CEO says

Read more

To category page